This compound is primarily known for its role as a potent inhibitor of spliceosome activity, which makes it a valuable tool in cancer research. It has been studied for its ability to selectively inhibit the splicing of pre-mRNA, a process critical for the survival of cancer cells. By disrupting this mechanism, it induces cell death in malignant cells, offering potential therapeutic applications in oncology. Researchers are exploring its use as a lead compound for developing novel anti-cancer drugs, particularly for targeting tumors that are resistant to conventional therapies. Additionally, it serves as a molecular probe to study the splicing process and its role in gene expression, aiding in the understanding of cellular mechanisms and disease pathways.